Cargando…

Quantitative MR Markers and Psychiatric Symptoms in a Patient with Fahr Disease

Patient: Female, 43 Final Diagnosis: Fahr disease Symptoms: Movement disorder • chorea and tremors • cognitive deficit • behavioral aggressiveness and restlessness • visual hallucination Medication: Haloperidolo • levomepromazine • sodium valproate Clinical Procedure: Neurology examination • neurops...

Descripción completa

Detalles Bibliográficos
Autores principales: Buono, Viviana Lo, Corallo, Francesco, Costa, Antonio, Bramanti, Placido, Marino, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485651/
https://www.ncbi.nlm.nih.gov/pubmed/26094250
http://dx.doi.org/10.12659/AJCR.893163
_version_ 1782378799442165760
author Buono, Viviana Lo
Corallo, Francesco
Costa, Antonio
Bramanti, Placido
Marino, Silvia
author_facet Buono, Viviana Lo
Corallo, Francesco
Costa, Antonio
Bramanti, Placido
Marino, Silvia
author_sort Buono, Viviana Lo
collection PubMed
description Patient: Female, 43 Final Diagnosis: Fahr disease Symptoms: Movement disorder • chorea and tremors • cognitive deficit • behavioral aggressiveness and restlessness • visual hallucination Medication: Haloperidolo • levomepromazine • sodium valproate Clinical Procedure: Neurology examination • neuropsychological examination • MRI Specialty: Neurology OBJECTIVE: Rare disease BACKGROUND: Fahr’s disease (FD), or primitive idiopathic calcification of the basal ganglia, is a rare neurodegenerative syndrome characterized by the presence of idiopathic bilateral and symmetrical cerebral calcifications. CASE REPORT: We describe the case of 43-year-old woman presenting with psychiatric symptoms, disorganized behavior, and migraine. Magnetic resonance imaging (MRI) examination showed basal ganglia calcifications. In addition, we analyzed the cortical brain volume and noted cortical atrophy. Extensive etiological clinico-biological assessment allowed us to exclude known causes of brain calcifications and to diagnose Fahr disease (FD). Neurological symptoms associated with psychiatric manifestations are not uncommon in FD. CONCLUSIONS: Purely psychiatric presentations are possible, as demonstrated by the present case, although there have been very few cases reported. To date, no studies related to the brain atrophy in FD have been reported.
format Online
Article
Text
id pubmed-4485651
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-44856512015-07-09 Quantitative MR Markers and Psychiatric Symptoms in a Patient with Fahr Disease Buono, Viviana Lo Corallo, Francesco Costa, Antonio Bramanti, Placido Marino, Silvia Am J Case Rep Articles Patient: Female, 43 Final Diagnosis: Fahr disease Symptoms: Movement disorder • chorea and tremors • cognitive deficit • behavioral aggressiveness and restlessness • visual hallucination Medication: Haloperidolo • levomepromazine • sodium valproate Clinical Procedure: Neurology examination • neuropsychological examination • MRI Specialty: Neurology OBJECTIVE: Rare disease BACKGROUND: Fahr’s disease (FD), or primitive idiopathic calcification of the basal ganglia, is a rare neurodegenerative syndrome characterized by the presence of idiopathic bilateral and symmetrical cerebral calcifications. CASE REPORT: We describe the case of 43-year-old woman presenting with psychiatric symptoms, disorganized behavior, and migraine. Magnetic resonance imaging (MRI) examination showed basal ganglia calcifications. In addition, we analyzed the cortical brain volume and noted cortical atrophy. Extensive etiological clinico-biological assessment allowed us to exclude known causes of brain calcifications and to diagnose Fahr disease (FD). Neurological symptoms associated with psychiatric manifestations are not uncommon in FD. CONCLUSIONS: Purely psychiatric presentations are possible, as demonstrated by the present case, although there have been very few cases reported. To date, no studies related to the brain atrophy in FD have been reported. International Scientific Literature, Inc. 2015-06-21 /pmc/articles/PMC4485651/ /pubmed/26094250 http://dx.doi.org/10.12659/AJCR.893163 Text en © Am J Case Rep, 2015 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License
spellingShingle Articles
Buono, Viviana Lo
Corallo, Francesco
Costa, Antonio
Bramanti, Placido
Marino, Silvia
Quantitative MR Markers and Psychiatric Symptoms in a Patient with Fahr Disease
title Quantitative MR Markers and Psychiatric Symptoms in a Patient with Fahr Disease
title_full Quantitative MR Markers and Psychiatric Symptoms in a Patient with Fahr Disease
title_fullStr Quantitative MR Markers and Psychiatric Symptoms in a Patient with Fahr Disease
title_full_unstemmed Quantitative MR Markers and Psychiatric Symptoms in a Patient with Fahr Disease
title_short Quantitative MR Markers and Psychiatric Symptoms in a Patient with Fahr Disease
title_sort quantitative mr markers and psychiatric symptoms in a patient with fahr disease
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485651/
https://www.ncbi.nlm.nih.gov/pubmed/26094250
http://dx.doi.org/10.12659/AJCR.893163
work_keys_str_mv AT buonovivianalo quantitativemrmarkersandpsychiatricsymptomsinapatientwithfahrdisease
AT corallofrancesco quantitativemrmarkersandpsychiatricsymptomsinapatientwithfahrdisease
AT costaantonio quantitativemrmarkersandpsychiatricsymptomsinapatientwithfahrdisease
AT bramantiplacido quantitativemrmarkersandpsychiatricsymptomsinapatientwithfahrdisease
AT marinosilvia quantitativemrmarkersandpsychiatricsymptomsinapatientwithfahrdisease